Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 5INDUSTRY 4OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Prostatic Neoplasms 134Urinary Bladder Neoplasms 47Kidney Neoplasms 38Carcinoma, Renal Cell 30Wilms Tumor 29Testicular Neoplasms 21Urethral Neoplasms 16Ovarian Neoplasms 15Neoplasm Metastasis 14Breast Neoplasms 14Neuroblastoma 12Sarcoma 11Teratoma 10Carcinoma, Non-Small-Cell Lung 9Testicular Germ Cell Tumor 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Ovarian Germ Cell Cancer 8Lung Neoplasms 8Endodermal Sinus Tumor 8Colorectal Neoplasms 7Burkitt Lymphoma 7Seminoma 6Osteosarcoma 6Neoplasms 6Colonic Neoplasms 6Carcinoma, Ovarian Epithelial 6Teratoma, Testicular 5Recurrence 5Pain 5Head and Neck Neoplasms 5

Interventions

tumor necrosis factor-alpha, CNGRC fusion protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Parathyroid Neoplasms × Genitourinary × Clear all
NCT00098943 2012-09-24

NGR-TNF in Treating Patients With Advanced Solid Tumors

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed
70 enrolled
CNSEndocrineGastrointestinalGenitourinaryHead & Neck

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Carcinoma, Renal Cell, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Parathyroid Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡